GET DAILY SIGNALSCLPT set to report a significant 75% increase in earnings per share on May 11th
CLPT, a company in the healthcare industry, has been on the rise despite a recent earnings miss. The last earnings report on December 31st showed a lower earnings per share than expected, but the company has since shown promising technical indicators.
With a P/B Ratio of 6.231 and a P/E Ratio of 0.000, CLPT is on par with comparable stocks in the industry. The PEG Ratio, which measures projected growth, is also within normal values. Although the company does not offer a dividend, the P/S Ratio is in line with the average among similar stocks.
One standout factor for CLPT is its recent upward trend. On April 6th, 2023, the stock moved above its 50-day moving average, indicating a change from a downward trend to an upward trend. In fact, A.I.dvisor has found that in 37 of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are currently at 90%.
Interestingly, A.I.dvisor also suggests a loose correlation between CLPT and another healthcare stock, OPK. These tickers have moved in lockstep 51% of the time over the past year, indicating a potential price increase for OPK if CLPT continues its upward trend.
While the recent earnings miss may have initially caused concern for investors, the positive technical indicators and upward trend suggest that CLPT is still a promising investment opportunity. As always, it is important to do your own research and consider all factors before making any investment decisions.
CLPT's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for CLPT turned positive on October 26, 2026. Looking at past instances where CLPT's MACD turned positive, the stock continued to rise in 46 of 54 cases over the following month. The odds of a continued upward trend are 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CLPT's RSI Indicator exited the oversold zone, 22 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +10.32% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLPT advanced for three days, in 217 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CLPT as a result. In 73 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The 50-day moving average for CLPT moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLPT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
CLPT broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CLPT entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CLPT's P/B Ratio (24.345) is slightly higher than the industry average of (4.142). P/E Ratio (-7.288) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (9.268) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. CLPT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a company, which engages in the development and commercialization of innovative platforms for performing minimally invasive surgical procedures in the brain and heart.
Industry MedicalNursingServices
Advertisement